{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:34:37Z","timestamp":1779878077922,"version":"3.53.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00259-017-3881-3","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T19:12:38Z","timestamp":1511291558000},"page":"622-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Comparison of 18F\u2013FDG PET\/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study"],"prefix":"10.1007","volume":"45","author":[{"given":"Lino M.","family":"Sawicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Grueneisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Ruhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahriye","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt M.","family":"Schaarschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forsting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"3881_CR1","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3892\/ol.2014.2362","volume":"8","author":"B Sorbe","year":"2014","unstructured":"Sorbe B, Juresta C, Ahlin C. Natural history of recurrences in endometrial carcinoma. Oncol Lett. 2014;8:1800\u20136. https:\/\/doi.org\/10.3892\/ol.2014.2362 .","journal-title":"Oncol Lett"},{"key":"3881_CR2","first-page":"21","volume":"93","author":"SC Rubin","year":"1999","unstructured":"Rubin SC, Randall TC, Armstrong KA, Chi DS, Hoskins WJ. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol. 1999;93:21\u20134.","journal-title":"Obstet Gynecol"},{"key":"3881_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/1097-0142(20000701)89:1<116::AID-CNCR16>3.0.CO;2-4","volume":"89","author":"T Maggino","year":"2000","unstructured":"Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer. 2000;89:116\u201322.","journal-title":"Cancer"},{"key":"3881_CR4","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.suronc.2011.12.008","volume":"21","author":"M Peiretti","year":"2012","unstructured":"Peiretti M, Zapardiel I, Zanagnolo V, Landoni F, Morrow CP, Maggioni A. Management of recurrent cervical cancer: a review of the literature. Surg Oncol. 2012;21:e59\u201366. https:\/\/doi.org\/10.1016\/j.suronc.2011.12.008 .","journal-title":"Surg Oncol"},{"key":"3881_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.ejso.2015.03.235","volume":"41","author":"H Sardain","year":"2015","unstructured":"Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Leveque J. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol. 2015;41:975\u201385. https:\/\/doi.org\/10.1016\/j.ejso.2015.03.235 .","journal-title":"Eur J Surg Oncol"},{"key":"3881_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11864-002-0060-x","volume":"3","author":"EM Salom","year":"2002","unstructured":"Salom EM, Penalver M. Recurrent vulvar cancer. Curr Treat Options in Oncol. 2002;3:143\u201353.","journal-title":"Curr Treat Options in Oncol"},{"key":"3881_CR7","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/bjc.2011.328","volume":"105","author":"RY Zang","year":"2011","unstructured":"Zang RY, Harter P, Chi DS, Sehouli J, Jiang R, Trope CG, et al. Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort. Br J Cancer. 2011;105:890\u20136. https:\/\/doi.org\/10.1038\/bjc.2011.328 .","journal-title":"Br J Cancer"},{"key":"3881_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2217\/whe.10.7","volume":"6","author":"SH Liyanage","year":"2010","unstructured":"Liyanage SH, Roberts CA, Rockall AG. MRI and PET scans for primary staging and detection of cervical cancer recurrence. Womens Health (Lond). 2010;6:251\u2013267; quiz 68-9. https:\/\/doi.org\/10.2217\/whe.10.7 .","journal-title":"Womens Health (Lond)"},{"key":"3881_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ejrad.2005.04.006","volume":"56","author":"EA Hauth","year":"2005","unstructured":"Hauth EA, Antoch G, Stattaus J, Kuehl H, Veit P, Bockisch A, et al. Evaluation of integrated whole-body PET\/CT in the detection of recurrent ovarian cancer. Eur J Radiol. 2005;56:263\u20138. https:\/\/doi.org\/10.1016\/j.ejrad.2005.04.006 .","journal-title":"Eur J Radiol"},{"key":"3881_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","volume":"71","author":"P Gu","year":"2009","unstructured":"Gu P, Pan LL, Wu SQ, Sun L, Huang G. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2009;71:164\u201374. https:\/\/doi.org\/10.1016\/j.ejrad.2008.02.019 .","journal-title":"Eur J Radiol"},{"key":"3881_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0090-8258(03)00409-8","volume":"91","author":"S Bipat","year":"2003","unstructured":"Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol. 2003;91:59\u201366.","journal-title":"Gynecol Oncol"},{"key":"3881_CR12","doi-asserted-by":"publisher","unstructured":"Wetter A, Grueneisen J, Umutlu L. PET\/MR imaging of pelvic malignancies. Eur J Radiol 2017. https:\/\/doi.org\/10.1016\/j.ejrad.2017.02.026.","DOI":"10.1016\/j.ejrad.2017.02.026."},{"key":"3881_CR13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/rli.0000000000000086","volume":"49","author":"J Grueneisen","year":"2014","unstructured":"Grueneisen J, Beiderwellen K, Heusch P, Gratz M, Schulze-Hagen A, Heubner M, et al. Simultaneous positron emission tomography\/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone. Investig Radiol. 2014;49:808\u201315. https:\/\/doi.org\/10.1097\/rli.0000000000000086 .","journal-title":"Investig Radiol"},{"key":"3881_CR14","unstructured":"The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute SEER Cancer Statistics In: NCI, editor.; 2017."},{"key":"3881_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jacr.2013.07.017","volume":"10","author":"DG Mitchell","year":"2013","unstructured":"Mitchell DG, Javitt MC, Glanc P, Bennett GL, Brown DL, Dubinsky T, et al. ACR appropriateness criteria staging and follow-up of ovarian cancer. J Am Coll Radiol. 2013;10:822\u20137. https:\/\/doi.org\/10.1016\/j.jacr.2013.07.017 .","journal-title":"J Am Coll Radiol"},{"key":"3881_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/ruq.0000000000000068","volume":"30","author":"N Lalwani","year":"2014","unstructured":"Lalwani N, Dubinsky T, Javitt MC, Gaffney DK, Glanc P, Elshaikh MA, et al. ACR appropriateness criteria(R) pretreatment evaluation and follow-up of endometrial cancer. Ultrasound Q. 2014;30:21\u20138. https:\/\/doi.org\/10.1097\/ruq.0000000000000068 .","journal-title":"Ultrasound Q"},{"key":"3881_CR17","doi-asserted-by":"publisher","first-page":"20160468","DOI":"10.1259\/bjr.20160468","volume":"89","author":"KL Michielsen","year":"2016","unstructured":"Michielsen KL, Vergote I, Dresen R, Op de Beeck K, Vanslembrouck R, Amant F, et al. Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study. Br J Radiol. 2016;89:20160468. https:\/\/doi.org\/10.1259\/bjr.20160468 .","journal-title":"Br J Radiol"},{"key":"3881_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1102\/1470-7330.2012.0007","volume":"12","author":"AG Rockall","year":"2012","unstructured":"Rockall AG, Cross S, Flanagan S, Moore E, Avril N. The role of FDG-PET\/CT in gynaecological cancers. Cancer Imaging. 2012;12:49\u201365. https:\/\/doi.org\/10.1102\/1470-7330.2012.0007 .","journal-title":"Cancer Imaging"},{"key":"3881_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ygyno.2006.02.016","volume":"103","author":"HH Chung","year":"2006","unstructured":"Chung HH, Kim SK, Kim TH, Lee S, Kang KW, Kim JY, et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecol Oncol. 2006;103:165\u201370. https:\/\/doi.org\/10.1016\/j.ygyno.2006.02.016 .","journal-title":"Gynecol Oncol"},{"key":"3881_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3346\/jkms.2010.25.7.1029","volume":"25","author":"SY Ryu","year":"2010","unstructured":"Ryu SY, Kim K, Kim Y, Park SI, Kim BJ, Kim MH, et al. Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease. J Korean Med Sci. 2010;25:1029\u201333. https:\/\/doi.org\/10.3346\/jkms.2010.25.7.1029 .","journal-title":"J Korean Med Sci"},{"issue":"Suppl 1","key":"3881_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1525-1438.2006.00471.x","volume":"16","author":"M Murakami","year":"2006","unstructured":"Murakami M, Miyamoto T, Iida T, Tsukada H, Watanabe M, Shida M, et al. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer. Int J Gynecol Cancer. 2006;16(Suppl 1):99\u2013107. https:\/\/doi.org\/10.1111\/j.1525-1438.2006.00471.x .","journal-title":"Int J Gynecol Cancer"},{"key":"3881_CR22","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s00259-009-1206-x","volume":"36","author":"E Mittra","year":"2009","unstructured":"Mittra E, El-Maghraby T, Rodriguez CA, Quon A, McDougall IR, Gambhir SS, et al. Efficacy of 18F-FDG PET\/CT in the evaluation of patients with recurrent cervical carcinoma. Eur J Nucl Med Mol Imaging. 2009;36:1952\u20139. https:\/\/doi.org\/10.1007\/s00259-009-1206-x .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3881_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00259-008-0956-1","volume":"36","author":"K Kitajima","year":"2009","unstructured":"Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Morita S, et al. Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT. Eur J Nucl Med Mol Imaging. 2009;36:362\u201372. https:\/\/doi.org\/10.1007\/s00259-008-0956-1 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3881_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ygyno.2006.10.060","volume":"105","author":"MM Thrall","year":"2007","unstructured":"Thrall MM, DeLoia JA, Gallion H, Avril N. Clinical use of combined positron emission tomography and computed tomography (FDG-PET\/CT) in recurrent ovarian cancer. Gynecol Oncol. 2007;105:17\u201322. https:\/\/doi.org\/10.1016\/j.ygyno.2006.10.060 .","journal-title":"Gynecol Oncol"},{"key":"3881_CR25","first-page":"994","volume":"28","author":"H YY","year":"2009","unstructured":"YY H, Sun XR, Lin XP, Liang PY, Zhang X, Fan W. Application of 18F-FDG PET\/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up. Ai Zheng. 2009;28:994\u20139.","journal-title":"Ai Zheng"},{"key":"3881_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00259-006-0251-y","volume":"34","author":"S Sironi","year":"2007","unstructured":"Sironi S, Picchio M, Landoni C, Galimberti S, Signorelli M, Bettinardi V, et al. Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET\/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging. 2007;34:472\u20139. https:\/\/doi.org\/10.1007\/s00259-006-0251-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3881_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00261-007-9218-0","volume":"33","author":"S Sebastian","year":"2008","unstructured":"Sebastian S, Lee SI, Horowitz NS, Scott JA, Fischman AJ, Simeone JF, et al. PET-CT vs. CT alone in ovarian cancer recurrence. Abdom Imaging. 2008;33:112\u20138. https:\/\/doi.org\/10.1007\/s00261-007-9218-0 .","journal-title":"Abdom Imaging"},{"key":"3881_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2967\/jnumed.115.158808","volume":"57","author":"C Spick","year":"2016","unstructured":"Spick C, Herrmann K, Czernin J. 18F-FDG PET\/CT and PET\/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients. J Nucl Med. 2016;57:420\u201330. https:\/\/doi.org\/10.2967\/jnumed.115.158808 .","journal-title":"J Nucl Med"},{"key":"3881_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00259-014-2902-8","volume":"42","author":"K Beiderwellen","year":"2015","unstructured":"Beiderwellen K, Grueneisen J, Ruhlmann V, Buderath P, Aktas B, Heusch P, et al. [(18)F]FDG PET\/MRI vs. PET\/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. Eur J Nucl Med Mol Imaging. 2015;42:56\u201365. https:\/\/doi.org\/10.1007\/s00259-014-2902-8 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3881_CR30","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.ejrad.2015.08.010","volume":"84","author":"J Grueneisen","year":"2015","unstructured":"Grueneisen J, Schaarschmidt BM, Heubner M, Suntharalingam S, Milk I, Kinner S, et al. Implementation of FAST-PET\/MRI for whole-body staging of female patients with recurrent pelvic malignancies: a comparison to PET\/CT. Eur J Radiol. 2015;84:2097\u2013102. https:\/\/doi.org\/10.1016\/j.ejrad.2015.08.010 .","journal-title":"Eur J Radiol"},{"key":"3881_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3802\/jgo.2012.23.4.242","volume":"23","author":"HJ Yoo","year":"2012","unstructured":"Yoo HJ, Lim MC, Seo SS, Kang S, Yoo CW, Kim JY, et al. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea. J Gynecol Oncol. 2012;23:242\u201350. https:\/\/doi.org\/10.3802\/jgo.2012.23.4.242 .","journal-title":"J Gynecol Oncol"},{"key":"3881_CR32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1634\/theoncologist.2002-0342","volume":"7","author":"M Friedlander","year":"2002","unstructured":"Friedlander M, Grogan M. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist. 2002;7:342\u20137.","journal-title":"Oncologist"},{"key":"3881_CR33","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1634\/theoncologist.2010-0091","volume":"15","author":"JA Rauh-Hain","year":"2010","unstructured":"Rauh-Hain JA, Del Carmen MG. Treatment for advanced and recurrent endometrial carcinoma: combined modalities. Oncologist. 2010;15:852\u201361. https:\/\/doi.org\/10.1634\/theoncologist.2010-0091 .","journal-title":"Oncologist"},{"key":"3881_CR34","doi-asserted-by":"publisher","first-page":"e0172553","DOI":"10.1371\/journal.pone.0172553","volume":"12","author":"J Kirchner","year":"2017","unstructured":"Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B, et al. Whole-body staging of female patients with recurrent pelvic malignancies: ultra-fast 18F-FDG PET\/MRI compared to 18F-FDG PET\/CT and CT. PLoS One. 2017;12:e0172553. https:\/\/doi.org\/10.1371\/journal.pone.0172553 .","journal-title":"PLoS One"},{"key":"3881_CR35","doi-asserted-by":"publisher","unstructured":"Sawicki LM, Deuschl C, Beiderwellen K, Ruhlmann V, Poeppel TD, Heusch P, et al. Evaluation of 68Ga-DOTATOC PET\/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET\/CT. Eur Radiol. 2017; https:\/\/doi.org\/10.1007\/s00330-017-4803-2 .","DOI":"10.1007\/s00330-017-4803-2"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3881-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T08:11:41Z","timestamp":1603354301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3881-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3881"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3881-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]}}}